NCT03326466

Brief Summary

In this case-control study, the investigators compare shoulder muscle function, pain, and central nervous system sensitization in patients with Subacromial Pain (SAP) to that in healthy controls. The investigators also examine if a relationship exists between shoulder symptom duration and central sensitization, shoulder muscle function and shoulder pain distribution in patients with SAP.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
72

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 12, 2017

Completed
19 days until next milestone

First Posted

Study publicly available on registry

October 31, 2017

Completed
13 days until next milestone

Study Start

First participant enrolled

November 13, 2017

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2020

Completed
Last Updated

February 21, 2019

Status Verified

February 1, 2019

Enrollment Period

2.7 years

First QC Date

October 12, 2017

Last Update Submit

February 20, 2019

Conditions

Keywords

Subacromial Impingement SyndromeCentral Nervous System SensitizationMuscle FunctionEMGForce SteadinessCUFF AlgometryManual AlgometryPainMaximal Voluntary Isometric Contraction

Outcome Measures

Primary Outcomes (9)

  • Maximal Voluntary Strength.

    Unit of Measure: Nm/Kg.

    Baseline assessment, no follow-up (cross-sectional study).

  • Submaximal Voluntary Force Steadiness

    Unit of Measure: Nm/Kg.

    Baseline assessment, no follow-up (cross-sectional study).

  • Maximal EMG

    Unit of Measure: mV/s. Will be recorded during the measurement of Maximal Voluntary Strength.

    Baseline assessment, no follow-up (cross-sectional study).

  • Submaximal EMG.

    Unit of Measure: mV/s. Will be recorded during the Measurement of Force Steadiness.

    Baseline assessment, no follow-up (cross-sectional study).

  • Central Nervous System Sensitization - Manual Algometry.

    Unit of Measure: kPa/s

    Baseline assessment, no follow-up (cross-sectional study).

  • Central Nervous System Sensitization - Cuff Algometry.

    Unit of Measure: kPa/s.

    Baseline assessment, no follow-up (cross-sectional study).

  • Patient Reported Outcome - Pain Mapping.

    Subject will draw their pain as accurately as possible on a high resolution 3D body schema. Area of Pain is quantified as total number of pixels, and will be expressed as percentage of body area.

    Baseline assessment, no follow-up (cross-sectional study).

  • Patient Reported Outcome - Shoulder Pain And Disability Index (SPADI).

    Questionnaire contains 13 items with a possible score from 0-100 (0=no disability).

    Baseline assessment, no follow-up (cross-sectional study).

  • Patient Reported Outcome - Pain Catastrophizing Scale (PCS).

    Questionnaire contains 13 items with a possible score 0-52. Higher score indicates higher level of pain catastrophizing.

    Baseline assessment, no follow-up (cross-sectional study).

Study Arms (2)

Patients with SAP

Healthy Controls

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Subacromial Pain.

You may qualify if:

  • Have had SAP during the last two weeks or more.
  • Have positive results from minimum 3 out of 5 clinical tests.
  • Have experienced pain ranking 4 or above on the VRS scale within the last 7 days.
  • Are able to speak and understand Danish.
  • Have given informed consent to participate in the study after they have fully understood the content of the study.

You may not qualify if:

  • Have acquired traumatic shoulder injury, and this is onset/cause for current shoulder pain, e.g. fall on shoulder.
  • Have received a corticosteroid injection within the last six weeks.
  • Report having had a shoulder fracture within 6 months.
  • Report having had surgery on the affected shoulder.
  • Report having radiologically verified glenohumeral osteoarthritis.
  • Have a luxation or sub-luxation of the glenohumeral or the acromioclavicular joint, clinically suspected labrum lesion, clinically suspected complete traumatic tear of the rotator cuff, frozen shoulder, suspected competing diagnoses (i.e. rheumatoid arthritis, cancer, neurological disorders, and fibromyalgia).
  • Have a history of diagnosed major psychiatric disorder.
  • Have a history of illicit drug use; be currently abusing alcohol or currently withdrawing from alcohol abuse.
  • Have a history of heart disease.
  • Are pregnant.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hvidovre University Hospital

Hvidovre, Sealand, 2650, Denmark

Location

MeSH Terms

Conditions

Shoulder Impingement SyndromePain

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal DiseasesShoulder InjuriesWounds and InjuriesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Thomas Bandholm, PhD

    Professor, Head of Research, PMR-C.

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MSc, PhD

Study Record Dates

First Submitted

October 12, 2017

First Posted

October 31, 2017

Study Start

November 13, 2017

Primary Completion

July 31, 2020

Study Completion

July 31, 2020

Last Updated

February 21, 2019

Record last verified: 2019-02

Data Sharing

IPD Sharing
Will share

We intend to make the data set - containing de-identified individual-patient data - publically available no later than 6 months after publication, consistent with the recent proposal from the International Committee of Medical Journal Editors (ICMJE), if it complies with national regulations, e.g. the Danish Data Protection Agency.

Locations